aamc.org does not support this web browser.

Advocacy & Policy

Advocacy & Policy

Two-page fact sheet detailing how J-1 and H-1B visa holders serve as an important complement within the health workforce, helping to fill gaps in the shortage.

  • PDF
Biomedical Research

Explore NIH grant funding data, including funding trends, funding by IC, new and competing awards, and multiyear funding, updated throughout the fiscal year.

Advocacy & Policy

A resource outlining Trump administration executive actions most likely to impact academic medicine.

About Our Advocacy

The AAMC works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Learn more about how the AAMC advocates on behalf of academic medicine.

Learn About Our Advocacy

Our Legislative and Policy Priorities

People with raised fists at a demonstration in the city

AAMC Action – Let’s Raise Our Voices Together

AAMC Action is a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us

Find Advocacy & Policy Content

  • Recent
  • Relevance
126 - 130 of 3794 results No filters applied
Testimony & Correspondence

AAMC Submits Comment to CMS on proposed rule that would prohibit Medicaid coverage of gender affirming care.

  • Feb. 17, 2026
  • PDF
Washington Highlights

The CMS proposed policies for insurance exchanges, including greater flexibility for issuers to offer catastrophic plans and expanded hardship exemptions.    

  • Feb. 13, 2026
Businessman filling in paperwork in an office
Washington Highlights

HRSA requests information on the impact of implementing a 340B Rebate Model Pilot Program.

  • Feb. 13, 2026
Washington Highlights

 The House Judiciary Committee majority leadership issued subpoenas to eight major health insurers regarding allegations of fraud and misuse in the APTCs.  

  • Feb. 13, 2026
Washington Highlights

The House Energy and Commerce Health Subcommittee held a hearing examining the prescription drug supply chain.  

  • Feb. 13, 2026
Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe